Prognostic value of longitudinal antinuclear antibody dynamics in rheumatoid arthritis: a retrospective cohort study
BackgroundThe prognostic value of longitudinal antinuclear antibody (ANA) dynamics in rheumatoid arthritis (RA) remains unclear.ObjectivesTo examine whether ANA development (titer rise/seroconversion) is associated with 12-month clinical remission and …